Bafna Pharmaceuticals informs about outcome of board meeting

12 Sep 2017 Evaluate

Bafna Pharmaceuticals has informed that the board of directors of the company, at its meeting held on 8th day of August, 2017 has considered and approved the Directors report; fixed date, place, and time of 22nd AGM; fixed Book Closure for 22nd AGM; fixed Cut-off Date for voting; to recommend the appointment of Statutory Auditor of the Company; to recommend the re-appointment of Managing Director of the Company; and to recommend the re-appoint of Whole time Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

164.20 -7.80 (-4.53%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×